Skip to main navigation Skip to main content Skip to page footer
  • Videos
  • Publications
  • Contact

Upgrading of Quality Infrastructure in Africa II – Pharma Component

OBJECTIVE

Upgrading of the Pan-African quality infrastructure supports the economic integration in Africa.

 

APPROACH

The aim of the pharmaceutical project component is to improve the framework conditions for the quality assurance of medical products in line with international standards. This, in turn, will create the basis for a functioning African Medicines Agency (AMA). To this end, the African Medicines Regulatory Harmonisation (AMRH) initiative and its technical committee responsible for quality control laboratories, the African Medicines Quality Forum (AMQF), are being supported to establish Africa-wide structures for quality assurance. Support measures include organising technical training sessions (virtual and on-site), networking events and proficiency tests. The national medicines regulatory authorities of the four focal countries – Senegal, Ghana, Rwanda and South Africa – will continue to receive special support for establishing quality management systems (QMS), while pharmaceutical companies will be trained in good manufacturing practices (GMP).

 

IMPACT

The project contributes to the establishment of a functioning African Medicines Agency (AMA) whose vision is to improve access to high-quality, safe and efficacious medical products on the African continent. Providing assistance to national regulatory authorities and their quality control laboratories will strengthen their regulatory frameworks and quality assurance processes. Supporting local pharmaceutical manufacturers of medicines and vaccines will lead to improved local production.

These measures will help improve access to health products and increase international comparability, recognition and competitiveness, all while reducing dependency on imports.

 

COOPERATION

The project works closely with GIZ health projects and with projects of the Global Health Protection Programme (GHPP) of the German Federal Ministry of Health (BMG). At a continental level, activities are coordinated with the WHO’s Coalition of Interested Parties (CIP) network and Africa Centres for Disease Control and Prevention (CDC).